Malignant Neoplasms of Brain: Clinical Trials

2 trials for Malignant Neoplasms of Brain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Malignant Neoplasms of Brain: new trials by email Literature Review of Malignant Neoplasms of Brain trials Research Report on Malignant Neoplasms of Brain

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
PEP-3-KLH conjugate vaccine, daclizumab, temozolomide - Malignant Neoplasms of Brain
Phase 1CompletedJohn Sampson162007-03-012016-01-21
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous lymphocytes - Malignant Neoplasms of Brain
Phase 1CompletedGary Archer Ph.D.422006-02-062023-03-13

Narrower conditions

Glioblastoma (2)  ·  Gliosarcoma (2)  ·  Glioma (1)

Broader conditions

Astrocytoma (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neoplasms, Neuroepithelial (2)  ·  Neuroectodermal Tumors (2)  ·  Glioma (1)

Interventions

Daclizumab (1)  ·  Temozolomide (1)  ·  Tetanus Toxoid (1)  ·  rindopepimut (1)

Sponsors

Gary Archer Ph.D. (1)  ·  John Sampson (1)

Countries

United States (2)

Top investigators

Duane Mitchell, MD, PhD (1)  ·  Katherine Peters, MD, PhD (1)

Results publications

PMID 22383993, PMID 25762141, PMID 28411277

NIH funding

R21CA132891 (1)